Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionVasopressin 1a (V1a) receptor antagonist
Molecular Target Vasopressin 1a (V1a) receptor
Mechanism of ActionVasopressin 1 (V1) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAutism
Indication DetailsTreat autism spectrum disorder (ASD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today